Securities code: Zhejiang Huakang Pharmaceutical Co.Ltd(605077) securities abbreviation: Zhejiang Huakang Pharmaceutical Co.Ltd(605077) Announcement No.: 2022010 Zhejiang Huakang Pharmaceutical Co.Ltd(605077)
Notice on subscription of shares issued by Ningbo traditional Chinese Medicine Pharmaceutical Co., Ltd
Progress announcement
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Zhejiang Huakang Pharmaceutical Co.Ltd(605077) (hereinafter referred to as “the company”) intends to subscribe for 8518000 shares issued by Ningbo traditional Chinese Medicine Pharmaceutical Co., Ltd. (hereinafter referred to as “Ningbo traditional Chinese medicine”) for RMB 21976440, sign the stock subscription contract with Ningbo traditional Chinese medicine and the supplementary agreement to the stock subscription contract with Fang Ming. For details, please refer to the website of Shanghai Stock Exchange on January 8 and February 8, 2022（ http://www.sse.com.cn. ）Announcement on the proposed subscription of directional shares issued by Ningbo traditional Chinese Medicine Pharmaceutical Co., Ltd. (2022001) and announcement on the progress of subscription of directional shares issued by Ningbo traditional Chinese Medicine Pharmaceutical Co., Ltd. (2022005).
Recently, the national small and medium-sized enterprise share transfer system Co., Ltd. examined and confirmed the application for directional issuance of Ningbo traditional Chinese medicine shares, and issued the letter on no objection to the directional issuance of Ningbo traditional Chinese medicine shares Co., Ltd. (stock transfer system letter [2022] No. 538) on March 10, 2022. This letter is valid for 12 months from the date of issuance.
The company will track the progress of relevant matters and fulfill the obligation of information disclosure in time according to the requirements of laws, regulations and normative documents. Please pay attention to investment risks. For detailed information on the directional issuance of shares by Ningbo traditional Chinese medicine, investors can log in to the information disclosure website designated by the share transfer system www.neeq.com com. cn. For reference.
It is hereby announced.
Zhejiang Huakang Pharmaceutical Co.Ltd(605077) board of directors March 11, 2022
